1. Home
  2. EVOK vs AMBO Comparison

EVOK vs AMBO Comparison

Compare EVOK & AMBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVOK
  • AMBO
  • Stock Information
  • Founded
  • EVOK 2007
  • AMBO 2000
  • Country
  • EVOK United States
  • AMBO United States
  • Employees
  • EVOK N/A
  • AMBO N/A
  • Industry
  • EVOK Biotechnology: Pharmaceutical Preparations
  • AMBO Other Consumer Services
  • Sector
  • EVOK Health Care
  • AMBO Real Estate
  • Exchange
  • EVOK Nasdaq
  • AMBO Nasdaq
  • Market Cap
  • EVOK 4.3M
  • AMBO 5.0M
  • IPO Year
  • EVOK 2013
  • AMBO 2010
  • Fundamental
  • Price
  • EVOK $4.41
  • AMBO $1.45
  • Analyst Decision
  • EVOK
  • AMBO
  • Analyst Count
  • EVOK 0
  • AMBO 0
  • Target Price
  • EVOK N/A
  • AMBO N/A
  • AVG Volume (30 Days)
  • EVOK 1.2M
  • AMBO 16.5K
  • Earning Date
  • EVOK 11-07-2024
  • AMBO 11-29-2024
  • Dividend Yield
  • EVOK N/A
  • AMBO N/A
  • EPS Growth
  • EVOK N/A
  • AMBO N/A
  • EPS
  • EVOK N/A
  • AMBO N/A
  • Revenue
  • EVOK $8,617,036.00
  • AMBO $9,163,000.00
  • Revenue This Year
  • EVOK $124.10
  • AMBO N/A
  • Revenue Next Year
  • EVOK $75.70
  • AMBO N/A
  • P/E Ratio
  • EVOK N/A
  • AMBO N/A
  • Revenue Growth
  • EVOK 100.35
  • AMBO N/A
  • 52 Week Low
  • EVOK $3.54
  • AMBO $1.00
  • 52 Week High
  • EVOK $17.40
  • AMBO $6.30
  • Technical
  • Relative Strength Index (RSI)
  • EVOK 40.54
  • AMBO 46.51
  • Support Level
  • EVOK $4.28
  • AMBO $1.33
  • Resistance Level
  • EVOK $4.79
  • AMBO $1.49
  • Average True Range (ATR)
  • EVOK 0.45
  • AMBO 0.16
  • MACD
  • EVOK -0.13
  • AMBO -0.01
  • Stochastic Oscillator
  • EVOK 22.82
  • AMBO 40.00

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

About AMBO Ambow Education Holding Ltd.

Ambow Education Holding Ltd is a provider of educational and career enhancement services in China. It operates through CP&CE Programs. The CP&CE Programs include tutoring services and career enhancement services. Geographically all the operations function in the United States and Foreign countries.

Share on Social Networks: